Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does MACITENTAN Cause Concomitant disease aggravated? 286 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 286 reports of Concomitant disease aggravated have been filed in association with MACITENTAN (OPSYNVI). This represents 0.6% of all adverse event reports for MACITENTAN.

286
Reports of Concomitant disease aggravated with MACITENTAN
0.6%
of all MACITENTAN reports
116
Deaths
211
Hospitalizations

How Dangerous Is Concomitant disease aggravated From MACITENTAN?

Of the 286 reports, 116 (40.6%) resulted in death, 211 (73.8%) required hospitalization, and 35 (12.2%) were considered life-threatening.

Is Concomitant disease aggravated Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for MACITENTAN. However, 286 reports have been filed with the FAERS database.

What Other Side Effects Does MACITENTAN Cause?

Dyspnoea (8,315) Death (5,864) Headache (4,856) Diarrhoea (3,669) Pneumonia (3,531) Nausea (3,463) Hospitalisation (3,414) Fatigue (3,172) Fluid retention (2,861) Dizziness (2,704)

What Other Drugs Cause Concomitant disease aggravated?

SACUBITRIL\VALSARTAN (533) SECUKINUMAB (461) FINGOLIMOD (425) OMALIZUMAB (186) SELEXIPAG (166) METHOTREXATE (150) RUXOLITINIB (142) OCTREOTIDE (125) BOSENTAN (123) EVEROLIMUS (123)

Which MACITENTAN Alternatives Have Lower Concomitant disease aggravated Risk?

MACITENTAN vs MACITENTAN\TADALAFIL MACITENTAN vs MAGNESIUM MACITENTAN vs MAGNESIUM ASPARTATE MACITENTAN vs MAGNESIUM ASPARTATE\POTASSIUM ASPARTATE MACITENTAN vs MAGNESIUM HYDROXIDE

Related Pages

MACITENTAN Full Profile All Concomitant disease aggravated Reports All Drugs Causing Concomitant disease aggravated MACITENTAN Demographics